Published in IBI on October 10, 2025, by Benjamin Wilkin
Wilkin, B., (2025) Comparing Organoids and Patient-derived Xenograft Models for the Development of Antibody-drug Conjugates - Crown Bioscience. https://blog.crownbio.com/comparing-organoids-and-patient-derived-xenograft-models-for-the-development-of-antibody-drug-conjugates
Cyclin-dependent kinases (CDKs) regulate cell-cycle progression and have long been investigated as therapeutic targets in oncology. The clinical succe…
Read more
Bringing more human-relevant methods into oncology drug development requires more than selecting a new platform: researchers need to establish where i…
Read more
Choosing the right preclinical immuno-oncology model makes or breaks your development decisions, but navigating the options is rarely simple. In this …
Read more
